We recently found that two different Cx43 mimetic peptides, the GAP26 and TAT-GAP19, distinctly affected the LPS-induced hemichannel activation in vitro, and divergently altered the sequelae of lethal sepsis in vivo40. This evidence concerns the gene GJA1 and Sepsis.